Literature DB >> 6605139

The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.

D F Benson, D E Kuhl, R A Hawkins, M E Phelps, J L Cummings, S Y Tsai.   

Abstract

Patients with Alzheimer's disease and multi-infarct dementia were studied with scans using fluorodeoxyglucose tagged with fluorine 18. The rates of glucose metabolism were calculated. Patients with Alzheimer's dementia showed decreased metabolism in all areas of the brain but with preferential sparing of the primary motor and sensory cortex. Patients with multi-infarct dementia also had global reductions in glucose metabolic rates when compared with normal control subjects, but the areas of hypometabolism were focal and asymmetric.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6605139     DOI： 10.1001/archneur.1983.04050110029003

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


  47 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease.

Authors:  Cunlu Xu; Zhenhua Wang; Ming Fan; Bing Liu; Ming Song; Xiantong Zhen; Tianzi Jiang
Journal:  Neuroreport       Date:  2010-08-23       Impact factor: 1.837

3.  Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?

Authors:  Torbjörn Sundström; Eva Elgh; Anne Larsson; Birgitta Näsman; Lars Nyberg; Katrine A Riklund
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-09       Impact factor: 9.236

Review 4.  Brain fuel metabolism, aging, and Alzheimer's disease.

Authors:  Stephen Cunnane; Scott Nugent; Maggie Roy; Alexandre Courchesne-Loyer; Etienne Croteau; Sébastien Tremblay; Alex Castellano; Fabien Pifferi; Christian Bocti; Nancy Paquet; Hadi Begdouri; M'hamed Bentourkia; Eric Turcotte; Michèle Allard; Pascale Barberger-Gateau; Tamas Fulop; Stanley I Rapoport
Journal:  Nutrition       Date:  2010-10-29       Impact factor: 4.008

5.  Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?

Authors:  S Hoyer; K Oesterreich; O Wagner
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

Review 6.  Molecular neuroimaging in Alzheimer's disease.

Authors:  William Jagust
Journal:  NeuroRx       Date:  2004-04

Review 7.  [Default mode network of the brain. Neurobiology and clinical significance].

Authors:  A Otti; H Gündel; A Wohlschläger; C Zimmer; C Sorg; M Noll-Hussong
Journal:  Nervenarzt       Date:  2012-01       Impact factor: 1.214

Review 8.  Brain imaging techniques in the diagnosis of dementia.

Authors:  A L Powell; D F Benson
Journal:  Neuropsychol Rev       Date:  1990-03       Impact factor: 7.444

9.  Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment.

Authors:  A Caroli; C Testa; C Geroldi; F Nobili; L R Barnden; U P Guerra; M Bonetti; G B Frisoni
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

10.  Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease.

Authors:  Qingli Shi; Hui Xu; Wayne A Kleinman; Gary E Gibson
Journal:  Biochim Biophys Acta       Date:  2007-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.